Kindernierenzentrum Bonn
- Address
- Im Muehlenbach 2b, Lengsdorf, 53127 Bonn, Germany
Kindernierenzentrum Bonn - Pediatric Nephrology Research Center
The Kindernierenzentrum Bonn is a specialized pediatric nephrology research center dedicated to advancing treatments for children and young adults with complex kidney diseases. The center demonstrates particular expertise in studying novel therapeutic approaches for chronic kidney disease (CKD) and its associated complications in pediatric populations, ranging from infants to adolescents.
- Proteinuria management in children with CKD, including studies of finerenone in combination with ACE inhibitors or angiotensin receptor blockers
- Anemia treatment associated with chronic kidney disease in pediatric patients, investigating agents such as roxadustat
- Rare kidney disorders including primary hyperoxaluria and complement 3 glomerulopathy
The center conducts comprehensive research evaluating both short-term efficacy and long-term safety of innovative medications, with particular focus on pharmacokinetics and pharmacodynamics in pediatric populations. Their research portfolio encompasses phase 3 clinical trials examining novel therapeutic mechanisms, from mineralocorticoid receptor antagonists to complement pathway inhibitors, demonstrating their commitment to advancing pediatric nephrology through evidence-based clinical investigation.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Compounds & Molecules Timeline
The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 2 161 other sites in Germany
Therapeutic Area Benchmark — Germany
Select a therapeutic area to compare against other sites in Germany.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: Germany
Market Share
Country: Germany
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in Kindernierenzentrum Bonn
lock Showing 1 of 6 trials — the rest is available on a paid plan.
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| A Phase 3, Open-label, Uncontrolled Study to Evaluate the Activity, Safety, Pharmacokinetics and Pharmacodynamics of Roxadustat for the Treatment of Anemia in Pediatric Participants with Chronic Kidney Disease | Astellas Pharma Global Development Inc. | Phase III | Recruiting | Dec 2023 | — |
IMP list
lock Showing 1 of 6 compounds — the rest is available on a paid plan.
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| Finerenone | 2 | Unknown | 2022-02-04 | 2022-11-07 |
Request feasibility information
Ask this centre about capacity, equipment and patient population.
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.